ADI webinar: The diagnostics revolution is now

As a follow up to our End of Year Forecast, ADI is pleased to highlight our second webinar 'The diagnostics revolution is now'

As a follow up to our End of Year Forecast, ADI is pleased to highlight our second webinar ‘The diagnostics revolution is now’

Time and accuracy issues, stigma, and a lack of specialist capacity, have been major barriers to diagnosis for Alzheimer’s disease and related dementias. In recent times we have been on the cusp of revolution in diagnostics and have been calling on health system preparedness and readiness. That diagnostics revolution, that we envisaged and hoped for, is happening right now!

Following on from ADI’s End of Year Forecast event in December 2025, we brought together the leading lights in this rapidly emerging diagnostics space, no longer to ask ‘are we ready’ but how are these new diagnostics being implemented, how are clinics and health systems integrating them, what are the barriers and solutions to their use, what are the training gaps and who is leading and innovating in the space.

We heard from a leading panel of experts about how new blood tests (blood-based biomarkers) are being introduced and integrated, advancements in CSF (cerebral spine fluid) testing, digital biomarkers in practice and the emergence of online and at home cognitive testing.

Underpinning all of this we heard from a person living with dementia, who has first-hand experience of the diagnostics pathway and true insight into how these emerging new tools can improve and set a new standard for diagnosis.

We also shined a light on how diagnostics are changing the face of clinical trial recruitment and gained invaluable insights into how one research project is testing the new blood tests in practice, tackling training alongside testing accuracy and efficacy.

Speakers included:

Mr Ashton Harper MD, Global Medical Affairs Lead for Neurosciences, Roche Diagnostics

Ms Fiona Carragher, Chief Policy and Research Officer, Alzheimer Society

Mr Kohei Sakata, Theoria CEO, Eisai group

Mr Howard Gordon,  Dementia advocate and former healthcare worker

Ms Beena Ahmed, Associate Professor, Electrical Engineering & Telecommunications, General Chair Interspeech 2026, Founder Say66